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Summary: This study evaluated real world driver errors and sleepiness in 66 
drivers with Obstructive Sleep Apnea (OSA) and 34 matched controls (24 younger 
and 22 older). Driving errors and driver state were derived from analyses of video 
data from “black-box” event recorders. Sleep fragmentation data in OSA was 
derived from actigraphy for 15 days prior to beginning standard treatment (positive 
airway pressure, PAP) and 15 days after beginning PAP treatment. Prior to starting 
PAP, OSAs appeared sleepier than controls in general and particularly at 
intersections, while making safety errors following nights with high levels of 
fragmented sleep compared to matched controls. Adverse effects of sleep 
fragmentation during the pre-PAP phase were reduced post-PAP. Greater hours of 
PAP-use were associated with lower sleepiness and errors on the road. PAP-use 
was associated with a decrease in high sleep fragmented nights. Findings suggest 
reduction in acute sleepiness is unlikely to be the only mediating factor that explains 
the driving safety benefits of PAP in OSA.  
 
OBJECTIVES 
 
Meta-analytic studies indicate that obstructive sleep apnea (OSA) is associated with increased 
crash risk (Treagear et al., 2009). Positive airway pressure (PAP), the standard treatment for 
OSA, appears to mitigate crash risk (Tregear et al., 2010). A major weakness of the studies to 
date is how crash risk is estimated. 67% of the studies in Tregear et al., (2009) were based on 
self-report, 22% on state records, and remaining 11% on insurance company records. Only 22% 
of PAP effectiveness studies were based on objective reports of crash risk (Tregear et al., 2010). 
Even when crash risk is estimated using state/insurance company records, it remains a poor 
measure of driving safety because crashes represent a fraction of the variability in driving safety 
(Heinrich et al., 1980). Many near-misses, other safety relevant errors that do not result in a crash 
because of the evasive maneuvers of other drivers are not reflected in crash statistics.  
 
These meta-analytic studies are inconclusive on why untreated OSA drivers may be at increased 
crash risk. While sleepiness from a variety of causes has been shown to be associated with 
increased crash risk (Connor et al, 2002), measures of chronic sleepiness such as the Epworth 
Sleepiness Scale have not shown significant associations with crash risk in OSA drivers (Tregear 
et al., 2009). In contrast, small sample and short-term (1-2 weeks) PAP-treatment studies show 
significant reductions in excessive daytime sleepiness and crash risk compared to pre-treatment 
baseline (Tregear et al., 2010) and improved vigilance in driving simulator outcomes for OSA 
drivers (e.g. Orth et al., 2005; Turkington et al., 2004). Chronic sleepiness may not be the main 
reason for decreased driving safety in OSA. Rather crash risk may depend more on the effects of 
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acute sleep deprivation associated with sleep fragmentation/ poor sleep hygiene. Connor et al., 
(2002) found that acute rather than chronic sleepiness based on retrospective interview data was 
associated with objective crash data in the general population. Acute sleep deprivation has also 
been shown to worsen simulated driving performance in both treated and untreated OSA to a 
greater extent than in matched controls (Filtness et al, 2011; Vakulin et al, 2009). Hence, OSA 
drivers may have an exaggerated deterioration in driving safety when sleep duration or quality is 
reduced. This study evaluated the effects of poor sleep quality (high sleep fragmentation) on 
driving safety and driver state in OSA. We examined these effects for 15 days before and 15 
days after PAP-therapy. We examined whether PAP-dose (measured by hours of use) was 
associated with driving outcomes in the post-PAP period and levels of sleep fragmentation. 
Compared to previous work, this study: a) measured driving safety errors and driver state 
including sleepiness from video using black-box event recorders, b) observed both OSAs for a 
two-week period prior to and a two-week period after PAP therapy, c) collected objective sleep 
quality data from actigraphy in both OSAs and controls d) presence/absence of OSA was 
confirmed with overnight polysomnography in both OSA and control drivers. We used these data 
to address two broad questions:  
1) Does sleep fragmentation adversely influence driving safety the next day in drivers with 
untreated OSA and matched controls pre-PAP period? Are the adverse effects of sleep 
fragmentation on driving safety larger for untreated OSA drivers than controls?  
2) How does PAP-treatment affect sleep fragmentation and the effects of sleep fragmentation on 
driving safety among OSAs? Are those relationships dependent on PAP-dose?  
 
METHOD  
 
Subjects 
 
Two groups of subjects, 66 diagnosed with OSA (26 female, age M = 46.8 years, SD = 7.47) and 
34 control participants (17 male, age = M = 44.2 years, SD = 8.4) from an ongoing study of real-
world driving in OSA were included in current report. In the broader study control participants 
were matched with OSA drivers at the group level on age within 5 years, education within 2 
years, and distribution of gender, county of residence for rural vs. urban driving. Patients met 
ICSD-2 clinical criteria for OSA and had a Respiratory Distress Index > 15, while controls had 
no sleep complaints and an RDI < 5 as confirmed by overnight sleep study.   
 
Study Procedures 
 
The design of the broader study called for naturalistic observations of OSA subjects driving their 
own vehicles using an instrumented vehicle data acquisition system (IV-DAS) for a 2-week 
period prior to beginning PAP treatment, and a period of 3-months after beginning PAP-use. 
Control drivers were evaluated at the same schedule to assure comparable data acquisition. To 
standardize PAP-use data collection, all OSA subjects were prescribed the same PAP-machine. 
Both control and OSA participants were also given actigraphy watches for the duration of the 
study. The data from the PAP-machines and watches were downloaded at monthly intervals. For 
the current report, only the 15 day-periods before and after the commencement of PAP-therapy 
were used.  
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Procedures Pertinent to Driving Data Collection. IV-DAS contains three devices: an internal 
camera cluster (ICC), a GPS, OBD-II, and accelerometers. The cameras are located underneath 
the rear view mirror, with one pointing forward toward the road (a driver’s eye view) and the 
other at the face and upper body of the driver. Electronic drive files and associated video clips 
were transmitted to a remote server daily. Video data collection was triggered intermittently 
based on accelerometer exceedances and a baseline data collection schedule (see Aksan et al., 
2011). Each ignition on-off cycle could be associated with three types of clips: one-minute 
ignition clips, trigger clips of minimum 20-seconds duration when the driver exceeded .35 g’s, 
and baseline clips of 20-seconds duration every 15-minute into a drive. Electronic data on 
vehicle state were not used in this report (see McLaurin et al., 2014). 
 
Measures  
 
PAP-adherence and objective sleep quality statistics. Nightly PAP-use data were downloaded 
during monthly visits in the post-PAP phase. Average minutes of use per night were used in the 
current report. Actigraphy watches report several statistics pertinent to sleep quality. In the 
current report, number of awakenings and number of minutes awake after sleep onset were used 
to index level of sleep fragmentation in the pre-PAP and post-PAP periods.  
 
Driving measures.  Clips were evaluated in 20-second segments in three broad domains: safety, 
exposure, and driver state. Table 1 provides examples of coded dimensions (Klauer et al., 2006; 
Neale et al., 2005; Wierville & Elsworth, 1994). Coders were trained on sample clips illustrating 
the range of behaviors in each of the dimensions listed in Table 1 until they showed the 
following minimum levels of inter-rater reliability: on categorical scales a Kappa of .61 and on 
continuously distributed scales minimum intra-class correlation of .71 for absolute agreement. 
All coders were blind to PAP-use and actigraphy data, some coders were also blind to group 
status. Presence/ absence of distracted behavior in several categories, safety errors, and facial/ 
bodily indicators of sleepiness were noted in 20-second segments. These binary judgments were 
transformed into relative frequency variables within a day, e.g. % time the driver appeared 
sleepy, distracted, made safety errors. In addition to these simple events, relative frequency of 
joint events was computed, e.g. % time the driver was negotiating an intersection while sleepy, 
% time driver made a safety error while sleepy, % time distracted at intersection or making 
safety errors while distracted at the day level. Because distraction can be a source of safety 
errors, these measures were included to permit an examination of whether the effects of sleep 
fragmentation and PAP-use on driving safety were specific to drivers’ sleepiness.  
 
Data reduction. Each night’s sleep statistics and PAP-use was linked with the following day’s 
driving data (e.g. relative frequency of safety errors while sleepy). Based on actigraphy data, 
each night was characterized as a low-to-moderate sleep fragmentation night or a high sleep 
fragmentation night. Sleep fragmentation was categorized as high if subjects had more than 30 
awakenings and more than 43 minutes awake after sleep onset. OSA and controls showed similar 
patterns of high vs. low-to-moderate sleep fragmentation in pre-PAP and post-PAP periods. 
Among controls, 79% in pre-PAP and 91% in the post-PAP period experienced high 
fragmentation, and among OSAs 85% in the pre-PAP and 89% in the post-PAP period 
experienced high fragmentation. Corresponding percentages for low-to-moderate sleep 
fragmentation were also similar across the groups and across pre to post-PAP periods.  
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Table 1. Coded dimensions in 20-second segments from each video clip in three domains of interest 
________________________________________________________________________________________________ 
Domain Dimension Examples        
Safety Errors Running stop signs/ lights, other traffic sign violations, turn errors, 
  lane keeping, accelerating or braking hard enough to exceed .35 g’s 
Driver State Distraction Included several categories, e.g. talking, singing, dancing, eating/  
  drinking, tending to personal hygiene (hair, teeth), cell-phone, etc. 
 Sleepiness Slow eye lid closure, fixed gaze, rubbing eyes, yawning, low  
  facial and bodily muscle tone, leaning/ holding neck/head    
Road Culture Intersection Sign or light controlled and uncontrolled intersections    
 
RESULTS  
 
Mixed linear models with maximum likelihood were fit to each of the joint and single event 
measures of driving. Group and level of sleep fragmentation the night before were the predictors. 
Unlike traditional ANOVA/ regressions these models accommodate various error covariance 
structures and missing data, permitting less biased inferences. The models were fit separately for 
the pre- and post-PAP periods. Table 2 shows p-values associated with the fixed effects. In all 
cases, the within and between subject variance components were statistically significant showing 
substantial intra- and inter-individual differences (not shown). The pre-PAP models (Figure 1) 
showed several interaction effects between sleep fragmentation and group. Of note, OSA drivers 
showed a pattern opposite that of matched controls on driving measures as a function of the level 
of sleep fragmentation the night before. OSA drivers appeared sleepier, made more safety errors 
while sleepy, and appeared sleepy during intersection negotiations on days following high levels 
of fragmented sleep. In contrast, the matched controls appeared less sleepy during intersection 
negotiation and less likely to make safety errors while sleepy following high levels of 
fragmented sleep in the pre-PAP period. None of these effects were observed in the post-PAP 
period (the last 3 columns of Table 2). However, there were significant main effects of group on 
overall sleepiness and likelihood of making a safety error while sleepy (see Figure 2). Controls 
were sleepier and made more safety errors while sleepy than OSAs in the post-PAP period. 
Importantly, effects of sleep fragmentation prominent for OSAs in the pre-PAP period were no 
longer observed in the post-PAP period.   
 
Table 2. Mixed model p-values for fixed effects as a function of sleep fragmentation and group on driving 
measures obtained the next day during the pre- and post-PAP periods 
________________________________________________________________________________________________________ 
Outcome measures pre-PAP post-PAP 
 Group  Sleep Group X Sleep Group Sleep Group X Sleep 
  Fragmentation Fragmentation  Fragmentation Fragmentation  
Driving measures the next day 
Single events (% time) 
 Safety errors .125 .510 .628 .067 .599 .213 
 Distracted .941 .960 .689 .586 .599 .833 
 Sleepy .296 .413 .035 .025 .080 .133 
Joint events (% time) 
 Sleepy & safety error .189 .005 .007 .035 .214 .334 
 Sleepy during intersection  
 negotiation .009 .038 .001 .248 .113 .126 
 Distracted & safety error .148 .404 .073 .134 .648 .778 
 Distracted during  
 intersection negotiation .181 .785 .724 .290 .485 .949   
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Figure 1. Effects of sleep fragmentation on real-world driving performance in untreated OSA and controls 
 
Figure 2. Effects of sleep fragmentation on real-world driving performance in OSA and controls post-PAP 
 
These findings suggest that PAP treatment itself may have diminished the adverse effects of 
sleep fragmentation on driving for OSAs. Higher hours of PAP-use were associated but at the 
trend level with lower levels of sleepiness in general (r= -.27, p <.10), lower levels of sleepiness 
both during safety errors and intersection negotiations (both r’s= -.30, p <.10). Mixed models 
examined changes in the number of days of high or low-to-moderate sleep fragmented from pre 
to post-PAP periods for OSA and controls (Table 3). In the pre-PAP period, OSAs and controls 
had similar numbers of days classified as high versus low-to-moderate sleep fragmented, all 
fixed effects ns. OSAs experienced an increase in low-to-moderate sleep fragmentation nights (p 
<.001 for the interaction of group by period), and a slight decrease in high fragmentation nights 
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(p = .05) from pre to post-PAP, while controls did not show a significant change in that time 
period. OSAs were not using PAP for shorter hours on low-to-moderate than high sleep 
fragmentation nights (3.85 and 3.6 respectively, ns).  
 
Table 3. Mean (SD) for number of days characterized as high versus low-to-moderate sleep fragmentation 
nights pre and post-PAP for OSAs and controls 
 Pre-PAP Post-PAP 
 OSA Control OSA Control 
High sleep fragmentation 6.1 (3.2) 5.7 (3.1) 5.3 (3.0) 6.2 (3.1)  
Low-to-moderate sleep fragmentation 5.1 (3.3) 6.1 (3.4) 6.7 (3.4) 5.2 (3.4) 
 
CONCLUSION 
 
This study provided novel information on whether sleep fragmentation adversely influences 
driving safety the next day in drivers with OSA and matched controls prior to PAP and after PAP 
treatment. They also showed how PAP-dosage affected association of sleep fragmentation with 
driving safety.  
 
Of note, OSA drivers appeared sleepier, made more safety errors while sleepy, and appeared 
sleepy during intersection negotiations on days following high levels of fragmented sleep prior to 
PAP treatment. In contrast, the matched control participants appeared less sleepy during 
intersection negotiations and less likely to be making safety errors while sleepy, possibly because 
they were driving more carefully by increasing following distance, stopping earlier at 
intersections, driving less rushed than OSAs following poor quality sleep nights. In contrast, the 
adverse sleep fragmentation effects were not observed for OSAs in the post-PAP period. In fact, 
controls were sleepier and made more safety errors while sleepy than OSAs post-PAP. The 
findings showed that the effects of sleep fragmentation as well as PAP were specific to drivers’ 
sleepiness behind the wheel, and were not associated with other possible sources of driver safety 
errors such as distraction. Collectively, those findings indicate that PAP-therapy changed the 
adverse effects of sleep fragmentation prominent for OSAs in the pre-PAP period. However, the 
mechanisms of change remain unclear. For example, PAP-dose was associated with driver state 
and safety but only at the trend level. Pre- vs. post-PAP period was associated with fewer high 
fragmentation nights and greater low-to-moderate fragmentation nights for OSAs in the post-
PAP period but they did not receive larger PAP-doses on low-to-moderate than high sleep 
fragmentation nights. It is important to note that the effects of sleep fragmentation on driving 
outcomes for OSAs versus controls remained in the opposite direction from pre-PAP to post-
PAP period. For controls, greater sleep fragmentation was associated with greater safety 
suggesting the presence of self-regulatory influences. It is possible PAP-use increases drivers’ 
alertness in ways which are only partially or poorly captured by sleepiness measures (Tippin et 
al., 2012). Future studies will need to rely on more refined data reduction schemes that include 
alertness among driver state measures to better understand how the effects of PAP and sleep 
fragmentation affect driver safety in OSA and controls.   
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